Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + dexmedetomidine intramuscular ratio study for dental sedation in autistic children
RBR-108hw8xtRecruiting
- Sponsor
- Faculdade de Odontologia da Universidade Federal de Alagoas
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of ketamine and dexmedetomidine in Autism Spectrum Disorder (ASD) (3 arms), sponsored by Faculdade de Odontologia da Universidade Federal de Alagoas. Primary endpoints: Oxygen saturation, Heart rate and 3 more. Started Nov 2025; status: recruiting.
02
Drugs
ketaminedexmedetomidine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on RBR-108hw8xt.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-108hw8xt.